Earnings History Data for Tourmaline Bio, Inc. (TRML) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Tourmaline Bio, Inc.
Tourmaline Bio Inc. is a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune diseases. The company's lead program includes TOUR006. Tourmaline Bio Inc., formerly known as Talaris Therapeutics Inc., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19-03-2024 | PM | TRML | Tourmaline Bio, Inc. | 878.00 | -0.81 | -0.75 | 0.00 | Tourmaline Bio GAAP EPS of -$8.87 [3/19/2024 10:32 AM] |
40.16 | 0.15 (0.37%) |
0.0 | 0.0 (0.00%) |
7.33 - 48.31 | 265,133 | 190,000 | 0 | ||